The potential for BRAF V600 inhibitors in advanced cutaneous melanoma: rationale and latest evidence
about
BRAF vs RAS oncogenes: are mutations of the same pathway equal? Differential signalling and therapeutic implicationsA graph theoretic approach to utilizing protein structure to identify non-random somatic mutations.The histogenic origin of melanoma arising in respiratory epithelium of a teratomatous germ cell tumor of the mediastinum: an enigma unraveled from an unlikely source.FDG-PET is a good biomarker of both early response and acquired resistance in BRAFV600 mutant melanomas treated with vemurafenib and the MEK inhibitor GDC-0973.Trametinib, a first-in-class oral MEK inhibitor mass balance study with limited enrollment of two male subjects with advanced cancers.Combination molecularly targeted drug therapy in metastatic melanoma: progress to date.The changing landscape of dermatology practice: melanoma and pump-probe laser microscopy.
P2860
Q28543370-BE855123-7A61-4E34-A276-39DFFA73EEC9Q30360645-4FA8AFB4-3B76-4310-9244-4E334CE61607Q41625409-C9AC4221-0642-4334-AEDD-88BEFE4E8222Q42250522-3E1B172D-FB5F-4E2A-BFB6-8D31A6A1ED08Q43543302-EE91C720-CE88-4AB1-BC95-61C3D648552CQ43877495-16054518-3F36-48A8-B88D-76A7F0425DBFQ47692272-439E522F-8F9F-45BA-8F8A-D002AC593560
P2860
The potential for BRAF V600 inhibitors in advanced cutaneous melanoma: rationale and latest evidence
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The potential for BRAF V600 in ...... rationale and latest evidence
@ast
The potential for BRAF V600 in ...... rationale and latest evidence
@en
type
label
The potential for BRAF V600 in ...... rationale and latest evidence
@ast
The potential for BRAF V600 in ...... rationale and latest evidence
@en
prefLabel
The potential for BRAF V600 in ...... rationale and latest evidence
@ast
The potential for BRAF V600 in ...... rationale and latest evidence
@en
P2860
P356
P1476
The potential for BRAF V600 in ...... rationale and latest evidence
@en
P2093
Hendrik-Tobias Arkenau
Jeffrey Infante
P2860
P356
10.1177/1758834011432949
P577
2012-03-01T00:00:00Z